The ERA-EDTA database on recurrent glomerulonephritis following renal transplantation

Nephrology Dialysis Transplantation

Volumn 29, Issue 1, 2014, Pages 15-21

  Floege, Jürgen ^a   Regele, Heinz ^b   Gesualdo, Loreto ^c  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

allograft failure; de novo glomerulonephritis; glomerulonephritis; recurrence; transplantation

Indexed keywords

ANCA ASSOCIATED VASCULITIS; DONOR SELECTION; FACTUAL DATABASE; FOCAL GLOMERULOSCLEROSIS; GLOMERULONEPHRITIS; GRAFT FAILURE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INFORMATION STORAGE; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LIVING DONOR; LUPUS ERYTHEMATOSUS NEPHRITIS; MEDICAL INFORMATION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; PATIENT CARE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW;

ALLOGRAFT FAILURE; DE NOVO GLOMERULONEPHRITIS; GLOMERULONEPHRITIS; RECURRENCE; TRANSPLANTATION;

ALLOGRAFTS; DATABASES, FACTUAL; DELAYED GRAFT FUNCTION; EDETIC ACID; GLOMERULONEPHRITIS; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; POSTOPERATIVE COMPLICATIONS; RECURRENCE;

EID: 84892771877     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft299     Document Type: Review

References (28)

1. Briganti EM, Russ GR, McNeil JJ et al. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 2002; 347: 103-109
2. Hariharan S, Peddi VR, Savin VJ et al. Recurrent and de novo renal diseases after renal transplantation: a report from the renal allograft disease registry. Am J Kidney Dis 1998; 31: 928-931
3. Mulay AV, van Walraven C, Knoll GA. Impact of immunosup-pressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis. Am J Transplant 2009; 9: 804-811
4. Golgert WA, Appel GB, Hariharan S. Recurrent glomerulone-phritis after renal transplantation: an unsolved problem. Clin J Am Soc Nephrol 2008; 3: 800-7
5. Ponticelli C, Glassock RJ. Posttransplant recurrence of primary glomerulonephritis. Clin J Am Soc Nephrol 2010; 5: 2363-2372
6. Moroni G, Longhi S, Quaglini S et al. The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival. Nephrol Dial Transplant 2012; in press
7. Cameron JS. Glomerulonephritis in renal transplants. Transplantation 1982; 34: 237-245
8. Hariharan S, Adams MB, Brennan DC et al. Recurrent and de novo glomerular disease after renal transplantation: A report from renal allograft disease registry (RADR). Transplantation 1999; 68: 635-641
9. Floege J. Recurrent glomerulonephritis following renal transplantation: an update. Nephrol Dial Transplant 2003; 18: 1260-1265
10. Briggs JD, Jones E. Recurrence of glomerulonephritis following renal transplantation. Scientific Advisory Board of the ERA-EDTA Registry. European Renal Association-European Dialysis and Transplant Association. Nephrol Dial Transplant 1999; 14: 564-565
11. Kukla A, Chen E, Spong R et al. Recurrent glomerulonephritis under rapid discontinuation of steroids. Transplantation 2011; 91: 1386-1391
12. Clayton P, McDonald S, Chadban S. Steroids and recurrent IgA nephropathy after kidney transplantation. Am J Transplant 2011; 11: 1645-1649
13. Odorico JS, Knechtle SJ, Rayhill SC et al. The influence of native nephrectomy on the incidence of recurrent disease following renal transplantation for primary glomerulonephritis. Transplantation 1996; 61: 228-234
14. European Best Practice Guidelines for Renal Transplantation (part 2). Nephrol Dial Transplant 2002; 17(Suppl 4): 1-60
15. Fornoni A, Sageshima J, Wei C et al. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med 2011; 3: 85ra46
16. Vinai M, Waber P, Seikaly MG. Recurrence of focal segmental glomerulosclerosis in renal allograft: an in-depth review. Pediatr Transplant 2010; 14: 314-325
17. Yabu JM, Ho B, Scandling JD et al. Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis. Am J Transplant 2008; 8: 222-227
18. Jhaveri KD, Naber TH, Wang X et al. Treatment of recurrent focal segmental glomerular sclerosis posttransplant with a multimodal approach including high-galactose diet and oral galactose supplementation. Transplantation 2011; 91: e35-36
19. Leroy S, Guigonis V, Bruckner D et al. Successful anti-TNFalpha treatment in a child with posttransplant recurrent focal segmental glomerulosclerosis. Am J Transplant 2009; 9: 858-861
20. Sprangers B, Lefkowitz GI, Cohen SD et al. Beneficial effect of ri-tuximab in the treatment of recurrent idiopathic membranous nephropathy after kidney transplantation. Clin J Am Soc Nephrol 2010; 5: 790-797
21. Lien YH, Scott K. Long-term cyclophosphamide treatment for recurrent type I membranoproliferative glomerulonephritis after transplantation. Am J Kidney Dis 2000; 35: 539-543
22. Muczynski KA. Plasmapheresis maintained renal function in an allograft with recurrent membranoproliferative glomerulonephri-tis type I. Am J Nephrol 1995; 15: 446-449
23. McCaughan JA, O'Rourke DM, Courtney AE. Recurrent dense deposit disease after renal transplantation: an emerging role for complementary therapies. Am J Transplant 2012; 12: 1046-1051
24. Chen Q, Muller D, Rudolph B et al. Combined C3b and factor B autoantibodies and MPGN type II. N Engl J Med 2011; 365: 2340-2342
25. Courtney AE, McNamee PT, Nelson WE et al. Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy? Nephrol Dial Transplant 2006; 21: 3550-3554
26. Mousson C, Charon-Barra C, Funes de la Vega M et al. Recurrence of IgA nephropathy with crescents in kidney transplants. Transplant Proc 2007; 39: 2595-2596
27. Westman KW, Bygren PG, Olsson H et al. Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulo-matosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol 1998; 9: 842-852
28. Stone JH, Millward CL, Olson JL et al. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era. Arthritis Rheum 1998; 41: 678-686